DMII Drugs Made In America Acquisition II Corp. - Ordinary Shares
NASDAQ · N/A close Oct 2, 2026DMII Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
DMII Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Not enough fundamentals data to compute this ratio group yet.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
Not enough fundamentals data to compute this ratio group yet.
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Institutional owners (13F) 68 filers · $428.4M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 7 (-12 vs prior Q) | 6 (+4 vs prior Q) | 15 (+4 vs prior Q) | 14 (-1 vs prior Q) | +2.5M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Karpus Management, Inc. | $28,047,260 | 2,787,998 | 6.55% | Shares |
| MMCAP International Inc. SPC | $27,162,000 | 2,700,000 | 6.34% | Shares |
| Magnetar Financial LLC | $27,162,000 | 2,700,000 | 6.34% | Shares |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | $22,569,035 | 2,241,215 | 5.27% | Shares |
| MILLENNIUM MANAGEMENT LLC | $20,055,193 | 1,993,558 | 4.68% | Shares |
| Hudson Bay Capital Management LP | $19,808,442 | 1,969,030 | 4.62% | Shares |
| WOLVERINE ASSET MANAGEMENT LLC | $18,663,533 | 1,855,222 | 4.36% | Shares |
| TENOR CAPITAL MANAGEMENT Co., L.P. | $15,090,000 | 1,500,000 | 3.52% | Shares |
| Polar Asset Management Partners Inc. | $15,090,000 | 1,500,000 | 3.52% | Shares |
| D. E. Shaw & Co., Inc. | $14,838,500 | 1,475,000 | 3.46% | Shares |
| AQR Arbitrage LLC | $11,380,536 | 1,131,266 | 2.66% | Shares |
| ARISTEIA CAPITAL, L.L.C. | $11,066,000 | 1,100,000 | 2.58% | Shares |
| Crossingbridge Advisors, LLC | $11,066,000 | 1,100,000 | 2.58% | Shares |
| First Trust Capital Management L.P. | $10,742,048 | 1,067,798 | 2.51% | Shares |
| Davidson Kempner Capital Management LP | $10,060,000 | 1,000,000 | 2.35% | Shares |
| OMERS ADMINISTRATION Corp | $10,060,000 | 1,000,000 | 2.35% | Shares |
| PICTON MAHONEY ASSET MANAGEMENT | $8,933,283 | 888,000 | 2.09% | Shares |
| TWO SIGMA INVESTMENTS, LP | $8,918,633 | 886,544 | 2.08% | Shares |
| Context Capital Management, LLC | $7,545,000 | 750,000 | 1.76% | Shares |
| Mercuria Capital Strategies, LLC | $7,545,000 | 750,000 | 1.76% | Shares |
| MOORE CAPITAL MANAGEMENT, LP | $7,545,000 | 750,000 | 1.76% | Shares |
| Ghisallo Capital Management LLC | $7,545,000 | 750,000 | 1.76% | Shares |
| Westchester Capital Management, LLC | $6,255,278 | 621,797 | 1.46% | Shares |
| Radcliffe Capital Management, L.P. | $5,791,753 | 575,721 | 1.35% | Shares |
| HighTower Advisors, LLC | $5,700,137 | 566,614 | 1.33% | Shares |
| JPMORGAN CHASE & CO | $5,598,426 | 555,951 | 1.31% | Shares |
| HEIGHTS CAPITAL MANAGEMENT, INC | $5,225,164 | 519,400 | 1.22% | Shares |
| TIG Advisors, LLC | $5,030,000 | 500,000 | 1.17% | Shares |
| SONA ASSET MANAGEMENT (US) LLC | $5,030,000 | 500,000 | 1.17% | Shares |
| HBK INVESTMENTS L P | $5,030,000 | 500,000 | 1.17% | Shares |
| BlueCrest Capital Management Ltd | $5,030,000 | 500,000 | 1.17% | Shares |
| WHITEBOX ADVISORS LLC | $4,527,000 | 450,000 | 1.06% | Shares |
| Wealthspring Capital LLC | $4,028,426 | 400,440 | 0.94% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $3,973,197 | 394,950 | 0.93% | Shares |
| Logan Stone Capital, LLC | $3,839,761 | 381,686 | 0.90% | Shares |
| CANTOR FITZGERALD, L. P. | $3,652,786 | 363,100 | 0.85% | Shares |
| COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS | $3,521,000 | 350,000 | 0.82% | Shares |
| Lineage Point Capital LP | $3,383,782 | 336,360 | 0.79% | Shares |
| Kryger Capital LLC | $3,063,682 | 304,541 | 0.72% | Shares |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | $3,039,000 | 300,000 | 0.71% | Shares |
| SkyView Investment Advisors, LLC | $2,515,000 | 250,000 | 0.59% | Shares |
| Periscope Capital Inc. | $2,263,500 | 225,000 | 0.53% | Shares |
| Clear Street Group Inc. | $2,262,283 | 224,879 | 0.53% | Shares |
| Verition Fund Management LLC | $2,040,570 | 202,840 | 0.48% | Shares |
| Shaolin Capital Management LLC | $1,815,669 | 180,484 | 0.42% | Shares |
| GABELLI & Co INVESTMENT ADVISERS, INC. | $1,805,770 | 179,500 | 0.42% | Shares |
| Limestone Investment Advisors LP | $1,519,060 | 151,000 | 0.35% | Shares |
| HGC Investment Management Inc. | $1,509,000 | 150,000 | 0.35% | Shares |
| GABELLI FUNDS LLC | $1,337,980 | 133,000 | 0.31% | Shares |
| Schonfeld Strategic Advisors LLC | $1,125,532 | 111,882 | 0.26% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Drugs Made In America Acquisition II LLC, Lynn Stockwell | Oct. 2, 2025 | 10.20% | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 6 insiders · 2 officers · 4 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Lynn Stockwell | CEO and Exe. Chair of Board | Sept. 26, 2025 P | 6,708,333 | 0 | 0 | $0 |
| Glenn C. Worman | CFO | Sept. 26, 2025 J | 100,000 | 0 | 0 | $0 |
| Catherine Do | Director | Sept. 26, 2025 J | 100,000 | 0 | 0 | $0 |
| Myron W. Shulgan | Director | Sept. 26, 2025 J | 100,000 | 0 | 0 | $0 |
| Sridhar G. Prasad | Director | Sept. 26, 2025 J | 100,000 | 0 | 0 | $0 |
| Drugs Made In America Acquisition II LLC | 10% owner | Sept. 26, 2025 P | 6,708,333 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.